Kareena Teh

Kareena Teh

Dechert LLP

Contact  |  View Bio  |  RSS

Latest Publications


A Sign of Things to Come: Securities and Futures Trends Analysis: Greater Corporate and Individual Accountability for Regulatory...

2008 marked the height of the global financial crisis. The intervening years have seen criticism of financial regulators, a variety of enforcement activities and a raft of regulatory reforms. Hong Kong and its Securities and...more

6/18/2015 - Enforcement Actions Financial Crisis Hong Kong Hong Kong Securities and Futures Commission (HKSFC) Regulatory Standards

Combating Unfair Competition: The Convergence of China’s Antitrust and Anti-Graft Enforcement Activities

Recent investigations and high profile convictions highlight the ongoing crackdown by China’s authorities against anti-competitive conduct. In their efforts to combat unfair competition, Chinese authorities have used both...more

10/7/2014 - Anti-Corruption Antitrust Investigations Automotive Industry China Enforcement Actions Life Sciences Popular Unfair Competition

Data Privacy and Cyber Security in Hong Kong: The New Enforcement Imperative

Introduction - Cyber security has gained increasing attention in recent years and cyber attacks have become more sophisticated and more frequent. Cyber attacks and other data breaches can affect millions of customers...more

10/7/2014 - Cybersecurity Data Breach Data Protection Enforcement Hong Kong Popular

China’s State Secret Laws: Avoiding Liability in Cross Border Litigation and Investigations

When complying with discovery obligations in cross border litigation or responding to document production requests from overseas regulators, multi-nationals operating in China have to comply with China’s state secret laws...more

6/18/2014 - China Compliance Cross-Border Foreign Corporations Investigations Multinationals Popular SEC State Secrets

China’s Anti-Graft Campaign: Implications for Multi-Nationals Operating in China

Chinese anti-corruption efforts historically targeted recipients of bribes, particularly government officials. In the past year, however, Chinese authorities have initiated a very public crackdown on bribe payers in the life...more

5/30/2014 - Bribery C-Suite Executives China Enforcement Actions Life Sciences Multinationals Popular

Legal and Ethical Risks of Healthcare Businesses in China

Recent disputes and controversies involving Chinese subsidiaries of foreign pharmaceutical companies have sounded warning bells on legal and ethical issues regarding participation in China’s rapidly growing and evolving...more

4/23/2014 - China Enforcement Actions FCPA Healthcare Pharmaceutical Industry Remuneration Risk Mitigation Trade Secrets UK Bribery Act

6 Results
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.